Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,333
Closed -$129K 13540
2022
Q2
$129K Sell
14,333
-1,087
-7% -$12.6K ﹤0.01% 11209
2022
Q1
$273K Sell
15,420
-4,807
-24% -$150K ﹤0.01% 10495
2021
Q4
$1.15M Buy
20,227
+1,447
+8% +$96.6K ﹤0.01% 6921
2021
Q3
$1.42M Buy
18,780
+13,493
+255% +$1.43M ﹤0.01% 6637
2021
Q2
$889K Sell
5,287
-1,320
-20% -$231K ﹤0.01% 8084
2021
Q1
$1.16M Buy
6,607
+3,480
+111% +$702K ﹤0.01% 7334
2020
Q4
$641K Buy
3,127
+547
+21% +$102K ﹤0.01% 7744
2020
Q3
$504K Buy
+2,580
New +$621K ﹤0.01% 7659

Other funds holding GOCO

Jeff Yass's GOCO Position: Q2 2026 in Review

Jeff Yass sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 15,392 shares — an estimated $23.2K sold.

Jeff Yass first reported a position in GOCO in Q3 2020 and held it in 12 quarters. The position peaked at $4.66M in Q1 2021. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Jeff Yass reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 15,392 GoHealth shares in Q2 2026, an estimated $23.2K.
  • Jeff Yass first reported a position in GoHealth in Q3 2020 and held it in 12 quarters.
  • Jeff Yass's GoHealth position peaked at $4.66M in Q1 2021.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.